IP Library Granted Patent US 7,776,540
Granted Patent B2
US 7,776,540 · App. 12/202,935 · Granted Aug 17, 2010

Method of treating skin inflammation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,776,540
App. No.
12/202,935
Granted
Aug 17, 2010
Kind
B2
Abstract

Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17 and/or IL-23.

Claims (9)

1. A method of treating skin inflammation in a subject comprising:

a) measuring IL-17A, IL-17F, or both, in a non-lesional psoriatic skin sample from said subject using real-time PCR,

b) determining that said subject exhibits at least 5-fold higher expression of IL-17A, IL-17F, or both, compared to a normal skin sample, and

c) administering an antagonist of IL-17 to effectively treat skin inflammation in said subject wherein said antagonist is an antibody or binding fragment thereof.

2. The method of claim 1 , wherein the skin inflammation is cutaneous inflammation.

3. The method of claim 2 , wherein the cutaneous inflammation is psoriasis.

4. The method of claim 1 , wherein the antibody or binding fragment thereof is a monoclonal antibody or binding fragment thereof.

5. The method of claim 1 , wherein the antibody or binding fragment thereof is a humanized antibody or binding fragment thereof.

6. The method of claim 1 , wherein the antibody or binding fragment thereof is a human antibody or binding fragment thereof.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →